C-RAD AB (publ), a global leader in Surface Guided Radiation Therapy (SGRT), is attending ESTRO 2026 in Stockholm with live demonstrations of its flagship Catalyst⁺ HD, including targeted workflow and interface improvements developed in close collaboration with the clinical community. Together, these reflect a renewed strategic direction for C-RAD: focused, customer-led innovation built around what clinicians have asked for and what treatment rooms actually need.
Trusted by leading cancer centers worldwide, Catalyst+ HD sets the standard for SGRT. Catalyst+ HD offers the largest field of view in SGRT — a hip-to-head surface capture treated as a single, continuous region of interest, making the system both highly versatile and future-proof. Structured light technology enables color projection directly onto the patient’s skin for intuitive, lighting-independent positioning, while non-rigid registration removes the need for manual region-of-interest definition entirely. At ESTRO 2026, C-RAD will also demonstrate two workflow updates developed directly from clinical feedback. The large field of view enables a new ergonomic setup workflow that guides patients into alignment before fine positioning begins creating a smoother, more efficient experience for both patient and clinician. This is accompanied by a redesigned user interface built to improve clarity and reduce cognitive load in busy treatment environments.
Catalyst+ LITE, the newest member of the Catalyst⁺ family, addresses a gap that has held many clinics back: how to adopt SGRT without committing to a full-scale system from day one. Delivering high-precision motion management and tattoo-less patient setup, its modular architecture allows clinics to start with a robust foundational system and upgrade seamlessly to Catalyst⁺ HD as their needs evolve — without hardware replacement. Together, the Catalyst⁺ family provides a clear path for any clinic looking to adopt or deepen their SGRT practice.
Additionally, C-RAD is offering dedicated Meet the Expert sessions at ESTRO 2026 — an opportunity for clinicians to explore the clinical benefits of SGRT in a focused, individual setting, ask questions relevant to their specific workflows, and speak directly with C-RAD’s product and clinical specialists.
Tomas Blomquist, CEO of C-RAD AB (publ), comments on the company’s direction:
“ESTRO 2026, hosted this year in our home country Sweden and in the beautiful capital of Stockholm, marks the beginning of a new chapter for C-RAD. Over the past months, we have listened closely to customers, clinical partners and frontline treatment teams, and those conversations are sharpening our focus and accelerating our transformation. Our ambition is to build a category leading oncology workflow platform that combines precision, intelligent workflows and patient centered innovation to help clinics deliver safer, more efficient radiotherapy at scale.”
C-RAD welcomes all ESTRO 2026 attendees to visit Booth C11:39 for live demonstrations and Meet the Expert sessions. Sessions can be booked in advance at the C-RAD ESTRO 2026 landing page.
